Quo vadis? Psychiatric Genetics, Neurogenetics and Neurodegeneration

Quo vadis? Psychiatric Genetics, Neurogenetics and Neurodegeneration

Bibliographic Details
Main Author:	Berit eKerner
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-01-01
Series:	Frontiers in Genetics
Subjects:	Environmental Exposure heterogeneity pleiotropy Amyotrophic lateral sclerosis (ALS) Genome-wide association studies (GWAS) risk gene identification
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fgene.2014.00467/full

Similar Items

Shared genetic risk loci between Alzheimer’s disease and related dementias, Parkinson’s disease, and amyotrophic lateral sclerosis
by: Michael Wainberg, et al.
Published: (2023-06-01)

What Can Machine Learning Approaches in Genomics Tell Us about the Molecular Basis of Amyotrophic Lateral Sclerosis?
by: Christina Vasilopoulou, et al.
Published: (2020-11-01)

Genome-wide genetic links between amyotrophic lateral sclerosis and autoimmune diseases
by: Chun Yu Li, et al.
Published: (2021-02-01)

Integrative genetic and single cell RNA sequencing analysis provides new clues to the amyotrophic lateral sclerosis neurodegeneration
by: Hankui Liu, et al.
Published: (2023-02-01)

Meta Analysis of Human AlzGene Database: Benefits and Limitations of Using C. elegans for the Study of Alzheimer's Disease and Co-morbid Conditions
by: Behrad Vahdati Nia, et al.
Published: (2017-05-01)

Multiple-Tissue Integrative Transcriptome-Wide Association Studies Discovered New Genes Associated With Amyotrophic Lateral Sclerosis
by: Lishun Xiao, et al.
Published: (2020-11-01)

Natural killer cells-related immune traits and amyotrophic lateral sclerosis: A Mendelian randomization study
by: Zhenxiang Gong, et al.
Published: (2022-09-01)

Genome-Wide Gene-Set Analysis Identifies Molecular Mechanisms Associated with ALS
by: Christina Vasilopoulou, et al.
Published: (2023-02-01)

Genome-Wide Gene-Set Analysis Approaches in Amyotrophic Lateral Sclerosis
by: Christina Vasilopoulou, et al.
Published: (2022-11-01)

Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer
by: Siddhartha P. Kar, et al.
Published: (2021-07-01)

Statistical methods to detect pleiotropy in human complex traits
by: Sophie Hackinger, et al.
Published: (2017-01-01)

Use of Mendelian Randomization to Examine Causal Inference in Osteoporosis
by: Jie Zheng, et al.
Published: (2019-11-01)

Multi-Trait Genome-Wide Association Study of Atherosclerosis Detects Novel Pleiotropic Loci
by: Tiffany R. Bellomo, et al.
Published: (2022-02-01)

Genetically Predicted Circulating Concentrations of Micronutrients and Risk of Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study
by: Changqing Mu, et al.
Published: (2022-01-01)

Natural Genetic Variation Underlying Tiller Development in Barley (Hordeum vulgare L)
by: Allison M. Haaning, et al.
Published: (2020-04-01)

Evidence based on Mendelian randomization and colocalization analysis strengthens causal relationships between structural changes in specific brain regions and risk of amyotrophic lateral sclerosis
by: Jiaying Shi, et al.
Published: (2024-03-01)

Associations of the circulating levels of cytokines with risk of amyotrophic lateral sclerosis: a Mendelian randomization study
by: Bin Liu, et al.
Published: (2023-02-01)

Concurrent multiple sclerosis and amyotrophic lateral sclerosis: where inflammation and neurodegeneration meet?
by: Li Grace, et al.
Published: (2012-01-01)

Multivariate GWAS of psychiatric disorders and their cardinal symptoms reveal two dimensions of cross-cutting genetic liabilities
by: Travis T. Mallard, et al.
Published: (2022-06-01)

Rare Variants in Neurodegeneration Associated Genes Revealed by Targeted Panel Sequencing in a German ALS Cohort
by: Stefanie Krüger, et al.
Published: (2016-10-01)

ALS-linked TDP-43M337V knock-in mice exhibit splicing deregulation without neurodegeneration
by: Seiji Watanabe, et al.
Published: (2020-01-01)

An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis
by: Melissa S Rotunno, et al.
Published: (2013-12-01)

Unraveling the Heterogeneity of ALS—A Call to Redefine Patient Stratification for Better Outcomes in Clinical Trials
by: Laura Tzeplaeff, et al.
Published: (2024-03-01)

Quantitative association between lead exposure and amyotrophic lateral sclerosis: a Bayesian network-based predictive study
by: Wenxiu Yu, et al.
Published: (2024-01-01)

LPG: A four-group probabilistic approach to leveraging pleiotropy in genome-wide association studies
by: Yi Yang, et al.
Published: (2018-06-01)

Medication use and risk of amyotrophic lateral sclerosis—a systematic review
by: Can Cui, et al.
Published: (2022-08-01)

Improving Association Studies and Genomic Predictions for Climbing Beans With Data From Bush Bean Populations
by: Beat Keller, et al.
Published: (2022-04-01)

Association Between Premorbid Body Mass Index and Amyotrophic Lateral Sclerosis: Causal Inference Through Genetic Approaches
by: Ping Zeng, et al.
Published: (2019-05-01)

The Role of Bioenergetics in Neurodegeneration
by: Taylor A. Strope, et al.
Published: (2022-08-01)

Until I say good-bye: my year of living with joy /
by: 595736 Spencer-Wendel, Susan author, et al.
Published: (c201)

Molecular Pathology of ALS: What We Currently Know and What Important Information Is Still Missing
by: Nikol Jankovska, et al.
Published: (2021-07-01)

The Metabolomic Profile in Amyotrophic Lateral Sclerosis Changes According to the Progression of the Disease: An Exploratory Study
by: Carmen Marino, et al.
Published: (2022-09-01)

Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis
by: Maruša Barbo, et al.
Published: (2023-01-01)

Novel cases of amyotrophic lateral sclerosis after treatment of cerebral arteriovenous malformations
by: Michael Linnebank, et al.
Published: (2016-11-01)

Management of patients with amyotrophic lateral sclerosis
by: Andrea Calvo, et al.
Published: (2008-09-01)

Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1G93A) of ALS
by: Gabriela Bortolança Chiarotto, et al.
Published: (2019-11-01)

Cell-based neurorestorotherapy in amyotrophic lateral sclerosis―Scientific truth should rely on facts, but not conjecture
by: Chen eLin, et al.
Published: (2011-12-01)

Genome-wide analyses identify NEAT1 as genetic modifier of age at onset of amyotrophic lateral sclerosis
by: Chunyu Li, et al.
Published: (2023-10-01)

Selecting Genetic Variants and Interactions Associated with Amyotrophic Lateral Sclerosis: A Group LASSO Approach
by: Sofia Galvão Feronato, et al.
Published: (2022-08-01)

Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis
by: Eleni Christoforidou, et al.
Published: (2020-04-01)